does masshealth cover tirzepatide As proposed cuts threaten access to GLP-1 medications, advocates are speaking out on how critical these treatments are—take action now and urge Massachusetts lawmakers to protect coverage and ensure continued access With Mass. cutting weight loss
Description
Ozempic and Wegovy: How Semaglutide Is Reshaping NHS Prescribing in 2025 In 2025, two drugs, Ozempic and Wegovy, are...

Super Berberine GlucoVantage
Very important study by @SherryShenMD @Neil_Iyengar et al about the benefit of the GLP-1 agonists in patients with breast cancer

We identify only lst-1 and sygl-1, two of a number of previously reported targets, as likely the sole primary mRNA transcriptional targets of GLP-1 signaling that promote the germline stem cell fate

-1 :

Food and Drug Administration approved tirzepatide (Zepbound) injection for chronic weight management in adults with a BMI of 30 or with a BMI of 27 or greater with Continue reading Tirzepatide approved for weight loss
